Vimarsana
Biggest News Aggregation in the World

Campaign Builder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Campaign Builder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Campaign Builder Today - Breaking & Trending Today

Oscar Health, Inc. (NYSE:OSCR) Q4 2023 Earnings Call Transcript - Vimarsana News

Oscar Health, Inc. (NYSE:OSCR) Q4 2023 Earnings Call Transcript

Oscar Health, Inc. beats earnings expectations. Reported EPS is $-0.66069, expectations were $-0.74. Oscar Health, Inc.

Top 15 Efficient Call Center Software In 2024 - Vimarsana News

Top 15 Efficient Call Center Software In 2024

Top 15 Efficient Call Center Software In 2024. Best and most efficient call center software will be discussed in this article. 

Oscar Health Announces Results for Third Quarter 2023 and Raises Full Year 2023 Adjusted EBITDA Outlook; New +Oscar Agreement - Vimarsana News

Oscar Health Announces Results for Third Quarter 2023 and Raises Full Year 2023 Adjusted EBITDA Outlook; New +Oscar Agreement

For the quarter ended September 30, 2023: Direct and Assumed Policy Premiums of $1.6 billion, a 5% decrease YoY Premiums earned of $1.4 billion, a 46% increase YoY Medical Loss Ratio of...

Lumeon Unveils Latest Evolution of Clinical Workflow Automation with Lumeon Conductor™ - Vimarsana News

Lumeon Unveils Latest Evolution of Clinical Workflow Automation with Lumeon Conductor™

/PRNewswire/ -- Lumeon, the pioneer in clinical workflow automation solutions for health systems, announced today the next evolution of its SaaS platform:...

FundsCap Introduces New Trading Program, Aims to Facilitate Trading Capital Access - Vimarsana News

FundsCap Introduces New Trading Program, Aims to Facilitate Trading Capital Access

Cork, Ireland, Sept. 29, 2023 (GLOBE NEWSWIRE) -- FundsCap, an Ireland-based company specializing in proprietary trading announces a new trading program for its customers. This new move by FundsCap comes along with an